Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|May 6, 2022
Predictive Value of Delta-Radiomics Texture Features in 0.35 Tesla Magnetic Resonance Setup Images Acquired During Stereotactic Ablative Radiotherapy of Pancreatic CancerGarrett Simpson, William Jin, Benjamin Spieler, et al.
Medical Physics|April 25, 2020
Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot studyGarrett Simpson, Benjamin Spieler, Nesrin Dogan, et al.
American Journal of Clinical Oncology|July 1, 2015
Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based StudyYaacov R Lawrence, Benzion Samueli, Ronald Levitin, et al.
Thoracic Cancer|May 11, 2022
Chemoradiation followed by adjuvant durvalumab in stage III non-small cell lung cancer: Real-world comparison of treatment outcomes to historical controls treated with chemoradiation aloneAkram Saad, Jeffrey Goldstein, Sarit Appel, et al.
Scientific Reports|November 24, 2021
Assessment of CT to CBCT contour mapping for radiomic feature analysis in prostate cancerRyder M Schmidt, Rodrigo Delgadillo, John C Ford, et al.
The Israel Medical Association Journal : IMAJ|May 1, 2017
Salvage Radiation Therapy for Biochemical Failure Following Radical ProstatectomyBenjamin Spieler, Jeffrey Goldstein, Yaacov R Lawrence, et al.
American Journal of Clinical Oncology|October 17, 2014
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?Jeffrey Goldstein, Einat Even-Sapir, Simona Ben-Haim, et al.
American Journal of Clinical Oncology|June 22, 2026
Stereotactic Body Radiation Therapy Combined With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Comprehensive Single-Arm Meta-Analysis ApproachJustin Dreyer, Raksha Narasimhan, Ana R Dias Neto, et al.
Radiation Oncology (London, England)|January 8, 2017
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?Akram Saad, Jeffrey Goldstein, Yaacov R Lawrence, et al.
Cancers|February 11, 2023
For Hepatocellular Carcinoma Treated with Yttrium-90 Microspheres, Dose Volumetrics on Post-Treatment Bremsstrahlung SPECT/CT Predict Clinical OutcomesCrystal Seldon Taswell, Matthew Studenski, Thomas Pennix, et al.
Pageof 3